Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer.
about
Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responsesImmunologic aspect of ovarian cancer and p53 as tumor antigen.Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors.Immunological and clinical effects of vaccines targeting p53-overexpressing malignancies.The role of p53 in the immunobiology of cutaneous squamous cell carcinoma.The clinical significance of autoantibodies in gastrointestinal malignancies: an overview.The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells.CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer.Pharmacological activation of p53 in cancer cellsCurrent vaccine updates for lung cancer.Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients.Generating p53-specific cytotoxic T lymphocytes by recombinant adenoviral vector-based vaccination in mice, but not man.p53-reactive T cells are associated with clinical benefit in patients with platinum-resistant epithelial ovarian cancer after treatment with a p53 vaccine and gemcitabine chemotherapy.Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interleukin-2 receptor antibody versus anti-thymocyte globulin.
P2860
Q24678759-E3B1D22B-DB03-43F1-9D28-5213CF1E9A99Q24814703-B6902AB9-26AA-4B94-95B3-C1FB86F88BA4Q33999909-F759031A-629F-4230-A641-A93BDB523852Q34898280-A56E1CA6-EB3F-4BAF-8449-585E0F9AFBFBQ35142669-0FD6E668-F825-44EE-8B40-AFD7752AF95DQ36764924-28169589-5C71-477D-83D6-5D39137F8551Q36766027-60FA7326-7EFC-4C33-BD95-08521EFEB464Q37040436-45E3C306-AD2F-4673-8F7B-43B73824A050Q37191174-31A96CD2-267C-428E-B2E6-F553B89E2876Q37706593-4AF13331-B2B6-4F98-9B05-65DD108D4D89Q40555883-3B9EC2B7-6DCB-4CC3-8A8B-D5382F31840CQ45887190-CC94A03C-9DB4-4D60-B0EA-268A25A79772Q47561666-8C71DA4E-5D51-4710-AD4C-5346B3E78B29Q51975777-4CD1AEB0-F7E7-43CE-91C7-F585D68D6FB8
P2860
Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Long lasting p53-specific T ce ...... ted primary colorectal cancer.
@en
Long lasting p53-specific T ce ...... ted primary colorectal cancer.
@nl
type
label
Long lasting p53-specific T ce ...... ted primary colorectal cancer.
@en
Long lasting p53-specific T ce ...... ted primary colorectal cancer.
@nl
prefLabel
Long lasting p53-specific T ce ...... ted primary colorectal cancer.
@en
Long lasting p53-specific T ce ...... ted primary colorectal cancer.
@nl
P2093
P2860
P1476
Long lasting p53-specific T ce ...... ted primary colorectal cancer.
@en
P2093
Drijfhout J
Franken KL
Offringa R
Tollenaar RA
P2860
P304
P356
10.1002/1521-4141(200101)31:1<146::AID-IMMU146>3.0.CO;2-T
P407
P577
2001-01-01T00:00:00Z